Current Drug Targets
Title:Meet Our Editorial Board Member
Volume: 22 Issue: 4
Author(s): T. Iwaki
Affiliation:
Export Options
About this article
Cite this article as:
Iwaki T. , Meet Our Editorial Board Member, Current Drug Targets 2021; 22 (4) . https://dx.doi.org/10.2174/138945012204210127151845
DOI https://dx.doi.org/10.2174/138945012204210127151845 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
18
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Delayed Cerebral Ischemia after Subarachnoid Hemorrhage: From Vascular Spasm to Cortical Spreading Depolarizations
Current Neurovascular Research Screening Aortic Drug Treatments Through Arterial Compliance Measurements
Current Vascular Pharmacology COVID-19 in Children: A Narrative Review
Current Pediatric Reviews In vivo Optical Molecular Imaging of Cardiovascular Diseases: Long Road Ahead
Current Molecular Imaging (Discontinued) Patent Selections
Recent Patents on Cardiovascular Drug Discovery Machine Learning in Healthcare
Current Genomics Intravitreal Bevacizumab for Diabetic Retinopathy
Current Diabetes Reviews Development of Nucleic Acid Drugs for Neurological Disorders
Current Topics in Medicinal Chemistry Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio as Biomarkers for Cardiovascular Surgery Procedures: A Literature Review
Reviews on Recent Clinical Trials Modeling Loss of Microvascular Wall Homeostasis during Glycocalyx Deterioration and Hypertension that Impacts Plasma Filtration and Solute Exchange
Current Neurovascular Research Chymase Inhibitor As a Novel Therapeutic Strategy for Anti-Vascular Remodeling
Vascular Disease Prevention (Discontinued) Multidrug-Resistance (MDR) Proteins Develops Refractory Epilepsy Phenotype:Clinical and Experimental Evidences
Current Drug Therapy Cerebral Aneurysm as an Exacerbating Factor in Stroke Pathology and a Therapeutic Target for Neuroprotection
Current Pharmaceutical Design IgG4 Related Syndrome: Another Multiorgan Disease in the Interest Field of Internal Medicine
Current Pharmaceutical Design Matrix Metalloproteinases as Valid Clinical Target
Current Pharmaceutical Design Efficient Vessel Segmentation Based on Proposed Adaptive Conditional Random Field Model
Recent Advances in Computer Science and Communications Prosthetic Valve Endocarditis: Diagnostic Approach and Treatment Options
Cardiovascular & Hematological Disorders-Drug Targets Myocardial Infarction Following Atherosclerosis in Murine Models
Current Drug Targets Proinflammatory Gene Polymorphisms and Ischemic Stroke
Current Pharmaceutical Design Virus-Associated Vasculitides
Current Immunology Reviews (Discontinued)